BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6499895)

  • 1. Crossover comparison of moxonidine and clonidine in mild to moderate hypertension.
    Plänitz V
    Eur J Clin Pharmacol; 1984; 27(2):147-52. PubMed ID: 6499895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of moxonidine and clonidine HCl in treating patients with hypertension.
    Plänitz V
    J Clin Pharmacol; 1987 Jan; 27(1):46-51. PubMed ID: 3316304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine.
    Rupp H; Maisch B; Brilla CG
    Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():251-62. PubMed ID: 8827948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual comparison of moxonidine and prazosin in hypertensive patients.
    Plänitz V
    Eur J Clin Pharmacol; 1986; 29(6):645-50. PubMed ID: 3709608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of moxonidine in elderly patients with resistant hypertension.
    Martin U; Hill C; O' Mahony D
    J Clin Pharm Ther; 2005 Oct; 30(5):433-7. PubMed ID: 16164488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes.
    Jacob S; Klimm HJ; Rett K; Helsberg K; Häring HU; Gödicke J
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):315-22. PubMed ID: 15216449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with moxonidine.
    Prichard BN
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():49-58. PubMed ID: 8068579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
    Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
    Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
    Kanniainen E; Heikkilä O; Jääskeläinen T; Lilja M; Jounela AJ
    Eur J Clin Pharmacol; 1985; 28(1):35-9. PubMed ID: 3886400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of guanabenz and clonidine in hypertensive patients.
    Kluyskens Y; Snoeck J
    Curr Med Res Opin; 1980; 6(9):638-43. PubMed ID: 6996935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new antihypertensive agent used in a clinical setting].
    Wetzels E; Raschig A; Kaiser HJ
    Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine.
    Hamilton BP; Mersey JH; Hamilton J; Kuzbida G; Pavlis R; Levinson P
    Clin Pharmacol Ther; 1984 Nov; 36(5):628-33. PubMed ID: 6488684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective antihypertensive therapy: blood pressure control with moxonidine.
    Prichard BN; Graham BR
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S38-48. PubMed ID: 8872298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG; Jain AK; Vargas R; Fillingim J
    Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose clonidine administration in the treatment of mild or moderate essential hypertension: results from a double-blind placebo-controlled study (Clobass). The Clobass Study Group.
    J Hypertens; 1990 Jun; 8(6):539-46. PubMed ID: 2165088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of labetalol and clonidine in hypertension.
    Lilja M; Jounela AJ; Karppanen H
    Eur J Clin Pharmacol; 1982; 21(5):363-7. PubMed ID: 7075640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of clonidine and practolol in the treatment of hypertension.
    Pitkäjärvi T; Ala-Laurila P; Torsti P; Ruosteenoja R
    Ann Clin Res; 1976 Feb; 8(1):48-54. PubMed ID: 779587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cardiac function after effective treatment of hypertensive emergencies with i.v. clonidine.
    Masotti G; Scarti L; Poggesi L; Bisi G; Gallini C; Neri Serneri GG
    Eur Heart J; 1984 Dec; 5(12):1036-42. PubMed ID: 6534750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.